Calyculin a reveals serine/threonine phosphatase protein phosphatase 1 as a regulatory nodal point in canonical signal transducer and activator of transcription 3 signaling of human microvascular endothelial cells

Journal of Interferon and Cytokine Research

Volumn 32, Issue 2, 2012, Pages 87-94

  Zgheib, Carlos ^a   Zouein, Fouad A ^a   Chidiac, Rony ^a   Kurdi, Mazen ^a,b   Booz, George W ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b LEBANESE UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CALYCULIN A; FOSTRIECIN; LEUKEMIA INHIBITORY FACTOR; OKADAIC ACID; PROTEIN P300; SERINE; STAT3 PROTEIN; TYROSINE;

ACETYLATION; ARTICLE; DEGRADATION; DIMERIZATION; DNA BINDING; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

CARCINOGENS; CELL LINE; CREB-BINDING PROTEIN; ENDOTHELIUM; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; MICROVESSELS; OXAZOLES; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; PROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 2; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84856721541     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0059     Document Type: Article

References (37)

1. Booz GW, Day JN, Baker KM. 2003. Angiotensin II effects on STAT3 phosphorylation in cardiomyocytes: evidence for Erkdependent Tyr705 dephosphorylation. Basic Res Cardiol 98:33-38. (Pubitemid 36163515)
2. Brasier AR. 2010. The nuclear factor-kB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86:211-218.
3. Bricambert J, Miranda J, Benhamed F, Girard J, Postic C, Dentin R. 2010. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBPdependent hepatic steatosis in mice. J Clin Invest 120: 4316-4331.
4. Coccheri S. 2007. Approaches to prevention of cardiovascular complications and events in diabetes mellitus. Drugs 67: 997-1026. (Pubitemid 46744476)
5. Dawood T, Schlaich MP. 2009. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation. Minerva Cardioangiol 57:687-704.
6. Ganne S, Winer N. 2008. Vascular compliance in the cardiometabolic syndrome. J Cardiometab Syndr 3:35-39.
7. Ghosh MK, Sharma P, Harbor PC, Rahaman SO, Haque SJ. 2005. PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells. Oncogene 24:7290-7300. (Pubitemid 41622233)
8. Grethe S, Pörn-Ares MI. 2006. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/ 2-ERK1/2 survival pathway in TNF-a induced endothelial apoptosis. Cell Signal 18:531-540. (Pubitemid 41790373)
9. Haridas V, Nishimura G, Xu ZX, Connolly F, Hanausek M, Walaszek Z, Zoltaszek R, Gutterman JU. 2009. Avicin D: a protein reactive plant isoprenoid dephosphorylates Stat 3 by regulating both kinase and phosphatase activities. PLoS One 4:e5578.
10. Hou T, Tieu BC, Ray S, Recinos Iii A, Cui R, Tilton RG, Brasier AR. 2008. Roles of IL-6-gp130 signaling in vascular inflammation. Curr Cardiol Rev 4:179-192.
11. Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D, Hartshorne DJ. 1989. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159:871-877. (Pubitemid 19101063)
12. Kelly JJ, Moore TM, Babal P, Diwan AH, Stevens T, Thompson WJ. 1998. Pulmonary microvascular and macrovascular endothelial cells: differential regulation of Ca2 + and permeability. Am J Physiol 274:L810-L819.
13. Kurdi M, Booz GW. 2007. Can the protective actions of JAKSTAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling. J Cardiovasc Pharmacol 50:126-141. (Pubitemid 47267738)
14. Lakshmi SV, Padmaja G, Kuppusamy P, Kutala VK. 2009. Oxidative stress in cardiovascular disease. Indian J Biochem Biophys 46:421-440.
15. Liang H, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB. 1999. Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. J Biol Chem 274: 19846-19851.
16. López Farré A, Casado S. 2001. Heart failure, redox alterations, and endothelial dysfunction. Hypertension 38:1400-1405. (Pubitemid 34033423)
17. Nian M, Lee P, Khaper N, Liu P. 2004. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94: 1543-1553. (Pubitemid 38856961)
18. O'Loghlen A, Pérez-Morgado MI, Salinas M, Martín ME. 2003. Reversible inhibition of the protein phosphatase 1 by hydrogen peroxide. Potential regulation of eIF2a phosphorylation in differentiated PC12 cells. Arch Biochem Biophys 417:194-202. (Pubitemid 36993795)
19. Poizat C, Puri PL, Bai Y, Kedes L. 2005. Phosphorylationdependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells. Mol Cell Biol 25:2673-2687. (Pubitemid 40381631)
20. Ray S, Lee C, Hou T, Boldogh I, Brasier AR. 2008. Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution. Nucleic Acids 36:4510-4520.
21. Ray S, Sherman CT, Lu M, Brasier AR. 2002. Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity. Mol Endocrinol 16: 824-836. (Pubitemid 34297750)
22. ResjöS, Oknianska A, Zolnierowicz S, Manganiello V, Degerman E. 1999. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/ threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A. Biochem J 341: 839-845. (Pubitemid 29389218)
23. Schiltz RL, Mizzen CA, Vassilev A, Cook RG, Allis CD, Nakatani Y. 1999. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem 274:1189-1192.
24. Schuringa JJ, Schepers H, Vellenga E, Kruijer W. 2001. Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett 495:71-76. (Pubitemid 32367976)
25. Sehgal PB. 2008. Paradigm shifts in the cell biology of STAT signaling. Semin Cell Dev Biol 19:329-340.
26. Togi S, Kamitani S, Kawakami S, Ikeda O, Muromoto R, Nanbo A, Matsuda T. 2009. HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A. Biochem Biophys Res Commun 379:616-620.
27. Walsh AH, Cheng A, Honkanen RE. 1997. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. FEBS Lett 416:230-234. (Pubitemid 27475370)
28. Winterbourn CC, Hampton MB. 2008. Thiol chemistry and specificity in redox signaling. Free Radic Biol Med 45:549-561.
29. Woetmann A, Nielsen M, Christensen ST, Brockdorff J, Kaltoft K, Engel AM, Skov S, Brender C, Geisler C, Svejgaard A, Rygaard J, Leick V, Odum N. 1999. Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc Natl Acad Sci USA 96:10620-10625. (Pubitemid 29442193)
30. Yang W, Hong YH, Shen XQ, Frankowski C, Camp HS, Leff T. 2001. Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors. J Biol Chem 276:38341-38344.
31. Yang XP, Irani K, Mattagajasingh S, Dipaula A, Khanday F, Ozaki M, Fox-Talbot K, Baldwin WM 3rd, Becker LC. 2005. Signal transducer and activator of transcription 3a and specificity protein 1 interact to upregulate intercellular adhesion molecule-1 in ischemic-reperfused myocardium and vascular endothelium. Arterioscler Thromb Vasc Biol 25:1395-1400. (Pubitemid 40923358)
32. Yuan LW, Gambee JE. 2000. Phosphorylation of p300 at serine 89 by protein kinase C. J Biol Chem 275:40946-40951. (Pubitemid 32054918)
33. Yuan LW, Soh JW, Weinstein IB. 2002. Inhibition of histone acetyltransferase function of p300 by PKCd. Biochim Biophys Acta 1592:205-211.
34. Yung LM, Leung FP, Yao X, Chen ZY, Huang Y. 2006. Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets 6:1-19. (Pubitemid 43803123)
35. Zhang Q, Raghunath PN, Xue L, Majewski M, Carpentieri DF, Odum N, Morris S, Skorski T, Wasik MA. 2002a. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J Immunol 168: 466-474. (Pubitemid 34014150)
36. Zhang T, Seow KT, Ong CT, Cao X. 2002b. Interdomain interaction of Stat3 regulates its Src homology 2 domain-mediated receptor binding activity. J Biol Chem 277:17556-17563. (Pubitemid 34967557)
37. Zhang X, Blenis J, Li HC, Schindler C, Chen-Kiang S. 1995. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267:1990-1994.